Urinary Catheters Market (2026 - 2033)

Urinary Catheters Market Summary

The global urinary catheters market size was valued at USD 6.5 billion in 2025 and is projected to grow from USD 6.9 billion in 2026 to USD 10.9 billion by 2033, at a CAGR of 6.7% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 35.0% in 2025. The growth of the urinary catheters industry is attributed to the rising prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia, and spinal cord injuries, which necessitate long-term catheterization.

The growing aging population and increasing number of surgical procedures and hospitalizations further fuel product demand. In addition, the expanding adoption of home healthcare and the rising preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheters, are accelerating market growth. Technological advancements, including antimicrobial coatings and silicone-based materials that enhance patient comfort and reduce infection risk, along with greater awareness among patients and caregivers about urinary management options, are expected to support the market’s expansion over the forecast period.

The rising burden of urinary incontinence is significantly driving the market growth, as an aging population and the increasing prevalence of conditions such as stress, urgency, and mixed incontinence have expanded the patient base requiring bladder management solutions. As more individuals experience moderate to severe leakage and reduced quality of life, demand for both intermittent and indwelling catheters that provide effective, reliable urine drainage has increased. The condition is also diagnosed due to improved awareness and better screening in primary care settings, further expanding treatment uptake. In addition, the rising number of patients with neurogenic bladder disorders, diabetes-related complications, and post-surgical incontinence has strengthened long-term catheter usage.

• According to a 2025 study published by the European Association of Urology, the average age of 722 respondents was 52.6 years. The large majority were Italian citizens, and most had completed secondary education. The prevalence of urinary incontinence in this population was 44.8%, meaning that nearly one in two middle-aged women experienced some degree of leakage. Stress urinary incontinence (SUI) was the most common subtype, affecting 39.1% of respondents, followed by urgency urinary incontinence (UUI) in 13.8% and mixed urinary incontinence (MUI) in 9.1%. In terms of severity, 19.6% of participants reported mild symptoms, 20.4% reported moderate symptoms, and 4.3% reported severe or very severe leakage

Furthermore, the rising prevalence of benign prostatic hyperplasia is projected to significantly boost the demand for urinary catheters in the coming years. Urinary catheters are vital in managing BPH by providing immediate relief from urinary retention and improving patients’ quality of life. For individuals affected by BPH, catheters facilitate urine drainage by bypassing the obstruction caused by an enlarged prostate. Given their critical role in symptom management and patient care, the increasing incidence of BPH is expected to drive sustained market growth.

Market Dynamics

The growth of the urinary catheters market is attributed to the rising prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia, and spinal cord injuries, which necessitate long-term catheterization. The growing aging population and increasing number of surgical procedures and hospitalizations further fuel product demand. In addition, the expanding adoption of home healthcare and the rising preference for minimally invasive and non-invasive urinary management solutions, such as external and intermittent catheters, are accelerating market growth. Technological advancements, including antimicrobial coatings and silicone-based materials that enhance patient comfort and reduce infection risk, along with greater awareness among patients and caregivers about urinary management options.

Driver: Rising burden of urinary incontinence

The rising burden of urinary incontinence is significantly driving the growth of the urinary catheters market, as an aging population and the increasing prevalence of conditions such as stress, urgency, and mixed incontinence have expanded the patient base requiring bladder management solutions. As more individuals experience moderate to severe leakage and reduced quality of life, demand for both intermittent and indwelling catheters that provide effective, reliable urine drainage has increased. The condition is also diagnosed due to improved awareness and better screening in primary care settings, further expanding treatment uptake. In addition, the rising number of patients with neurogenic bladder disorders, diabetes-related complications, and post-surgical incontinence has strengthened long-term catheter usage.

• According to a 2025 study published by the European Association of Urology, the average age of 722 respondents was 52.6 years. The large majority were Italian citizens, and most had completed secondary education. The prevalence of urinary incontinence in this population was 44.8%, meaning that nearly one in two middle-aged women experienced some degree of leakage. Stress urinary incontinence (SUI) was the most common subtype, affecting 39.1% of respondents, followed by urgency urinary incontinence (UUI) in 13.8% and mixed urinary incontinence (MUI) in 9.1%. In terms of severity, 19.6% of participants reported mild symptoms, 20.4% reported moderate symptoms, and 4.3% reported severe or very severe leakage.

Restraint: High risk of catheter-associated urinary tract infections

The high risk of catheter-associated urinary tract infections significantly restrains the growth of the urinary catheters market, as it limits clinical adoption and long-term use. Healthcare providers are cautious about prolonged catheterization due to the strong association between indwelling catheters and hospital-acquired infections, which can lead to complications, extended hospital stays, higher treatment costs, and even increased patient morbidity. Thus, many hospitals are implementing stricter catheter-use protocols, early removal policies, and infection-prevention guidelines, thereby reducing overall catheter utilization rates.

Opportunity: Technological advancements in the catheter

Technological advancements in urinary catheters present a significant opportunity for market growth by improving patient safety, comfort, and clinical outcomes. Innovations such as antimicrobial and silver-coated catheters help reduce the risk of catheter-associated urinary tract infections, which remain a major concern in long-term catheterization. Similarly, the development of hydrophilic-coated catheters enhances lubrication, reducing friction during insertion and minimizing urethral trauma and patient discomfort. The increasing use of silicone-based catheters also improves biocompatibility and reduces encrustation, thereby supporting longer, safer use. In addition, emerging smart catheter systems with sensors for real-time monitoring of urine output and detection of blockages are expected to enhance hospital efficiency and patient management.

• In October 2025, Lotus Medical Technologies LLC announced the global expansion of its Lotus Catheter, an FDA-cleared urinary catheter designed as a non-balloon alternative to traditional Foley catheters. The device uses soft, collapsible wing technology instead of an inflatable balloon, aiming to reduce urethral trauma, minimize residual urine, and lower the risk of catheter-associated urinary tract infections.

The increasing demand for external catheters designed for home care settings is anticipated to be a major growth driver for the urinary catheters industry over the forecast period. With rising awareness of non-invasive urinary management solutions, healthcare providers and caregivers are favoring safer and more comfortable alternatives to traditional indwelling catheters. Industry feedback has been highly positive, underscoring the strong market potential for these products. A key instance is BD’s PureWick System, which has garnered consistent support from patients, caregivers, and healthcare professionals. As of August 2024, more than 50 million PureWick Female External Catheters and over 5 million PureWick Male External Catheters have been utilized across acute and home care environments, reflecting the growing adoption of external catheter solutions.

The development is growing the urinary catheters market by expanding access to user-friendly and home-based catheterization options, encouraging a shift toward external catheter systems and self-care solutions. As more patients adopt these alternatives for long-term bladder management, demand increases not only in hospitals but also in home healthcare settings, thereby broadening the market base and driving product adoption.

For instance, in 2026, Wellspect will launch the advanced Surity Urinary Management System and male external catheter later this year. Surity Female External Catheter is now available for home purchase and will soon be available to healthcare institutions.

Severe urinary incontinence affects millions of women, many of whom live with multiple health conditions. The impact of severe urinary incontinence reaches far beyond the inconvenience of leaks, contributing to sleep loss, emotional distress, and exhaustion for both patients and their caregivers," - Chris Schlenk, Group Vice President, Wellspect HealthCare

The increasing volume of orthopedic surgeries, particularly knee replacement procedures, is significantly contributing to the growth of the urinary catheters market. During major orthopedic operations such as total knee arthroplasty, hip replacement, and spinal surgeries, urinary catheters are routinely used to manage perioperative urinary retention and to ensure accurate monitoring of urine output under anesthesia. Since these procedures involve prolonged operative times and limited patient mobility post-surgery, catheterization becomes essential for patient comfort and clinical management in the immediate recovery phase. In addition, the rising prevalence of osteoarthritis, sports injuries, and age-related joint degeneration is driving higher surgical volumes globally, especially among the aging population. This translates into increased short-term catheter use in hospitals and ambulatory surgical centers. According to the data published by the Organization for Economic Co-operation and Development in 2025, the following table shows the number of knee replacement surgeries in 2023.

Knee replacement surgery in 2023, per 100,000 population

Country	2023 Value	% Increase (2013-2023)
Switzerland	318.3	48.60%
Germany	267.9	41.10%
Australia	263.8	38.10%
Finland	263.5	30.70%
Austria	234.5	8.90%
Luxembourg	226.7	13.30%
Canada	224.9	31.60%
France	204.8	41.10%
Sweden	172.2	25.20%
Korea	171.8	42.00%
Italy	171.7	64.60%
Slovenia	169.2	56.80%

Source: OECD 2025

Technological Advancements

Company Name	Product Launch	KOLs
Becton, Dickinson and Company	In November 2025, Becton, Dickinson and Company announced the expansion of its PureWick portfolio with the launch of the PureWick Portable Collection System, a first-of-its-kind, battery-powered urine management device designed for individuals with urinary incontinence. The system is specifically developed to support wheelchair users, enhancing mobility both at home and outside.	"Urinary incontinence is a common yet under-discussed condition that impacts 25 million Americans and can have profound effects on confidence, social engagement and quality of life, especially among those with mobility challenges, With the launch of the PureWick Portable Collection System, we have an opportunity to help people regain their confidence and independence by delivering a discreet, accessible solution that empowers individuals to participate more fully in everyday activities." - Mike Cusack, worldwide president of Urology and Critical Care at BD.
InnoCare Urologics	In August 2024, InnoCare Urologics received U.S. FDA approval for its InnoCare Specialty Foley Catheter.	" We saw a clear need to innovate a catheter design that has seen minimal advancement since its introduction over 80 years ago,” said Bryan Pinchuk, CEO and founder of InnoCare Urologics. “The creation of this new classification code validates the need to provide a safer alternative to traditional Foley catheters. We are excited to bring a technology to market for millions of high-risk patients, and this milestone is a critical step in achieving that goal.”

Source: Johnson & Johnson MedTech, Establishment Labs Holdings Inc., Grand View Research

Market Concentration & Characteristics

The urinary catheters market is characterized by a small group of large global medical device manufacturers that hold significant shares due to strong distribution capabilities, established supply chains, and broad product portfolios, alongside a broader base of regional and local manufacturers operating in cost-sensitive and emerging markets. This structure creates a layered competitive environment where advanced, technology-driven products dominate high-value hospital segments, while price-driven offerings remain prominent in developing regions. The industry is highly regulated, with strict compliance standards governing product safety, sterility, and biocompatibility. Innovation is a key characteristic, particularly in the development of antimicrobial coatings, hydrophilic surfaces, and silicone-based materials to reduce catheter-associated urinary tract infections and improve patient comfort. Demand is primarily driven by hospital procedures, long-term care facilities, and home healthcare settings, with usage closely linked to surgical interventions, chronic urological conditions, and the growing elderly population.

The urinary catheters industry is witnessing a high degree of innovation, driven by continuous advancements in material science, infection control, and device design to improve patient comfort and safety. Recent regulatory approvals highlight this innovation trend. For instance, InnoCare Urologics’ FDA approval of the InnoCare Specialty Foley Catheter in August 2024, and Urotronic’s (Laborie) FDA approval of the Optilume BPH Catheter System demonstrate the industry’s focus on addressing unmet clinical needs and enhancing treatment outcomes. Innovations such as antimicrobial and hydrophilic coatings, silicone-based and latex-free materials, and sensor-equipped catheter systems for real-time monitoring are transforming urinary management practices. These developments collectively indicate a strong momentum toward safer, more efficient, and patient-centric catheter solutions.

Regulations play a critical role in shaping the market, as stringent standards ensure product safety, efficacy, and quality, which are essential for patient care. Regulatory approvals from authorities such as the U.S. FDA and the European CE marking induce market entry, product design, and adoption rates. Compliance with guidelines for materials, sterilization, and infection control not only safeguards patients but also drives innovation, as manufacturers develop advanced catheters that meet regulatory requirements. While these regulations can increase development timelines and costs, they ultimately enhance market credibility, boost healthcare provider confidence, and support the global growth of safe and effective urinary catheter solutions. 

In March 2026, Prodeon Medical announced that it had received U.S. FDA 510(k) clearance for the Urocross Expander System, a novel non-permanent, retrievable implant designed for the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia.

The level of mergers and acquisitions (M&A) activity in the urinary catheters market is moderate, reflecting ongoing efforts by companies to expand their product portfolios, access advanced technologies, and strengthen market presence. Strategic acquisitions enable companies to integrate innovative solutions, enhance clinical offerings, and accelerate growth, underscoring the importance of M&A as a key driver for market consolidation and technological advancement.

The market faces moderate risk from product substitutes, as several alternative urinary management solutions are available that can reduce the reliance on traditional catheterization. These substitutes include external collection devices such as condom catheters and intermittent self-catheterization kits. In addition, medications that manage urinary retention or alleviate symptoms of benign prostatic hyperplasia and incontinence can reduce the immediate need for catheter use in certain patients. While these alternatives offer advantages in comfort, reduced infection risk, and ease of use, catheters remain essential for patients requiring continuous or long-term drainage, surgical care, or acute hospital interventions. The presence of substitutes encourages manufacturers to innovate and improve catheter designs, materials, and patient-centric features to maintain market relevance.

The urinary catheters industry exhibits a diversified end-user concentration, with demand spread across hospitals, long-term care facilities, and home healthcare settings. Hospitals and surgical centers represent the largest segment, driven by high patient volumes, the need for perioperative and acute care catheterization, and stringent infection control protocols. Long-term care facilities also contribute significantly, as residents require chronic catheterization for mobility or health-related issues. Meanwhile, the home healthcare segment is growing rapidly due to increasing preference for self-care, the adoption of non-invasive urinary management solutions, and rising awareness among patients and caregivers. This varied end-user base ensures market demand is well distributed, supporting growth across multiple healthcare settings. 

Analyst Perspective

The urinary catheter market is experiencing significant growth driven by the rising prevalence of urinary incontinence, benign prostatic hyperplasia (BPH), urinary retention, neurogenic bladder disorders, and the increasing number of surgical procedures requiring perioperative urinary management. Market participants are focusing on the development of advanced catheter technologies, including antimicrobial-coated catheters, hydrophilic catheters, and silicone-based products, to improve patient comfort and reduce the risk of catheter-associated urinary tract infections (CAUTIs). The growing shift toward intermittent catheterization, increasing adoption of home healthcare services, and expanding reimbursement coverage in developed markets are expected to support revenue growth.

Product Insights

The intermittent catheters segment led the urinary catheters market with a 57.7% revenue share in 2025, and external catheters are expected to grow at the fastest CAGR over the forecast period. The growth is attributed to a greater preference for silicone implants, driven by their widespread adoption across hospitals, long-term care facilities, and home healthcare settings. Intermittent catheters are preferred for their reduced risk of urinary tract infections, ease of use, and suitability for self-catheterization, which empowers patients to manage their condition independently. The growing awareness among patients and caregivers about safe urinary management practices and advancements in catheter materials, such as hydrophilic and silicone options, further contributed to the segment’s dominance.

The external catheters segment is expected to grow significantly over the forecast period, driven by increasing demand for non-invasive, comfortable urinary management solutions. External catheters, including condom and female external devices, are preferred in home care and outpatient settings due to their ease of application and lower infection risk compared with indwelling catheters. Rising awareness of external catheter options, coupled with technological innovations such as improved adhesion, leakproof designs, and enhanced patient comfort, is expected to accelerate adoption and drive market growth in this segment.

Application Insights

The urinary incontinence segment led the urinary catheters industry, accounting for 37.2% revenue share in 2025. The growth is due to the high prevalence of incontinence across all age groups, particularly among the elderly population. The increasing incidence of chronic conditions such as diabetes, neurological disorders, and mobility impairments further drives the need for catheterization to manage urinary leakage effectively. In addition, growing awareness among patients and caregivers about safe and hygienic urinary management solutions and the availability of advanced intermittent and external catheters contributed to the segment’s market dominance.

The Benign Prostate Hyperplasia (BPH) segment is expected to grow at the fastest CAGR over the forecast period. This growth can be attributed to the rising prevalence of prostate enlargement among aging men. Catheters play a critical role in providing immediate relief from urinary obstruction and associated symptoms, enhancing patient comfort and quality of life. Increasing awareness about minimally invasive treatments and the adoption of specialized BPH catheter systems, such as the FDA-approved Optilume BPH Catheter, are further fueling growth, positioning the segment for rapid market expansion.

Coating Type Insights

The coated catheters segment led the market, accounting for 61.4% of revenue in 2025, and is expected to grow at the fastest CAGR over the forecast period. This growth is primarily driven by its ability to reduce urinary tract infections and enhance patient comfort, with antimicrobial and hydrophilic coatings widely preferred across hospitals, long-term care facilities, and home healthcare settings. Growing awareness among healthcare providers and patients about infection prevention, along with the ease of use and improved safety these catheters offer, reinforced their market dominance. The rising adoption of advanced catheter technologies, the increasing prevalence of chronic urological conditions, the expanding home healthcare services, and ongoing innovations in coating materials and antimicrobial properties.

Uncoated catheters are witnessing significant growth in the urinary catheters industry, due to their cost-effectiveness, wide clinical availability, and strong adoption in price-sensitive healthcare systems, particularly in emerging economies and high-volume hospital settings. Despite the faster growth of coated variants, uncoated catheters continue to maintain substantial demand because they remain the most affordable and widely accessible option for routine catheterization and large-scale hospital use, especially where budget constraints limit the adoption of advanced coated technologies.

Material Insights

The silicone segment led the market, accounting for 42.9% revenue share in 2025, owing to its superior biocompatibility, reduced risk of latex allergy, lower encrustation rates, and suitability for long-term catheterization. Silicone catheters are widely preferred in hospitals, long-term care facilities, and home care settings due to their durability, enhanced patient comfort, and compatibility with a broad range of clinical applications. Furthermore, the increasing preference for premium catheter materials and the growing prevalence of chronic urinary disorders are supporting the continued dominance.

The silicone-coated latex segment is expected to grow at the fastest CAGR over the forecast period, owing to its ability to combine the cost-effectiveness and flexibility of latex with the improved biocompatibility and reduced tissue irritation offered by a silicone coating. The segment is gaining traction, particularly in emerging markets, where healthcare providers seek affordable alternatives to all-silicone catheters that do not compromise patient comfort or performance. In addition, advancements in coating technologies and increasing demand for long-term urinary drainage solutions are anticipated to further drive the growth of silicone-coated latex catheters.

Gender Insights

The male segment led the urinary catheters market with the largest revenue share of 63.4% in 2025. This growth is primarily driven by the higher prevalence of urological conditions such as benign prostatic hyperplasia and urinary retention among men. Male catheters, including intermittent and indwelling types, are extensively used across hospitals, long-term care facilities, and home healthcare settings, contributing to the segment’s substantial market share. The established adoption of male catheter solutions and the need for effective management of male-specific urinary disorders have reinforced this dominance.

The female segment is expected to grow at the fastest CAGR over the forecast period. This growth can be attributed to the increasing awareness of urinary incontinence management and the rising adoption of female-specific catheter designs. The demand for comfortable, easy-to-use, and non-invasive catheter solutions is growing among female patients, particularly in home care and outpatient settings, which is expected to propel rapid growth in this segment. Innovations tailored for female anatomy and patient-centric designs further support the expansion of the female catheter market.

Distribution Channel Insights

The direct tenders segment led the urinary catheters industry, accounting for 51.7% revenue share in 2025, owing to high-volume procurement of urinary catheters by hospitals, long-term care facilities, and government healthcare institutions through centralized purchasing contracts and tender-based agreements. Indwelling (Foley) catheters, which constitute a significant portion of overall catheter demand, are primarily utilized in inpatient and acute care settings, further supporting institutional procurement. In addition, leading manufacturers maintain dedicated sales teams and long-term supply agreements with healthcare providers, enabling direct procurement and ensuring consistent product availability.

Online channels are expected to grow at the fastest CAGR over the forecast period, driven by increasing adoption of intermittent self-catheterization, growing preference for home healthcare, and expanding e-commerce platform penetration. Patients requiring long-term catheterization increasingly prefer online purchasing channels for convenience, discreet ordering, subscription-based delivery, and a wider range of product options. In addition, rising awareness of advanced catheter technologies, improved internet accessibility, and manufacturers' expansion of direct-to-consumer sales strategies are further supporting market growth. The trend is particularly prominent in developed markets, where favorable reimbursement policies and increasing demand for home-based management of chronic urological conditions are accelerating the adoption of online channels.

End Use Insights

The hospitals segment led the urinary catheters market, accounting for 52.2% revenue share in 2025. This growth can be attributed to the high number of patients requiring catheterization for acute care, surgical procedures, and perioperative management. Hospitals remain the primary setting for short-term and long-term catheter use, supported by skilled healthcare professionals, strict infection control protocols, and ready access to a wide range of catheter types, including intermittent, indwelling, and coated catheters. The demand is further driven by the prevalence of urological disorders, chronic diseases, and post-operative care requirements, making hospitals the largest end-user segmen.

The long-term care facilities segment is expected to witness significant growth during the forecast period due to the increasing number of elderly individuals requiring continuous bladder management for age-related conditions, urinary incontinence, neurogenic bladder, and chronic illnesses. Residents in long-term care facilities often need prolonged or intermittent catheterization because of reduced mobility, cognitive impairment, and dependence on caregivers for daily activities. The rising prevalence of chronic diseases, coupled with longer life expectancy and expanding long-term care infrastructure, has further increased the demand for safe and infection-resistant urinary catheter solutions in these settings.

Regional Insights

North America dominated the urinary catheters market, accounting for the largest revenue share of 35.0% in 2025. The growth is driven by a combination of demographic, clinical, and technological factors. A key driver is the rising prevalence of urological conditions such as urinary incontinence, benign prostatic hyperplasia, and bladder dysfunction, particularly among the aging population. According to the U.S. Census Bureau, the number of individuals aged 65 and older is increasing rapidly, fueling demand for long-term catheterization and specialized urological care. The region’s well-established healthcare infrastructure, strong reimbursement systems, and efficient distribution networks ensure broad access to urinary catheters across hospitals, nursing homes, and home healthcare settings. In addition, growing awareness of urological health and self-catheterization techniques has supported the adoption of intermittent catheters, enabling patients to manage their conditions with greater autonomy and improving quality of life.

U.S. Urinary Catheters Market Trends

The U.S. urinary catheters industry held the largest share of North America in 2025. The market growth is primarily driven by technological advancements, changing patient preferences, and evolving healthcare practices. There is a growing shift toward intermittent and external catheters, which are perceived as safer, more comfortable, and suitable for home care settings. Innovations such as antimicrobial coatings, hydrophilic surfaces, and drug-eluting catheters enhance patient safety by reducing infection risks and improving usability. In addition, increased adoption of minimally invasive urological procedures and rising awareness of self-catheterization techniques empower patients to manage their conditions independently.

The rising incidence of cancer cases, such as urinary bladder cancer and other abdominal malignancies, in the U.S. is increasing the demand for urinary catheters, as many patients require catheterization during diagnosis, surgical procedures, chemotherapy, and post-operative recovery. Bladder cancer patients experience urinary obstruction, hematuria management needs, or undergo procedures such as tumor resection, which necessitate short-term or long-term catheter use. Patients with gallbladder and other pelvic or abdominal cancers require catheter support during surgery and intensive care management to ensure proper urinary drainage and monitoring.

Europe Urinary Catheters Market Trends

The Europe urinary catheters industry is growing, driven by a combination of demographic, clinical, and policy factors. A key contributor is the region’s aging population, which is leading to an increased prevalence of age-related urological conditions, including urinary incontinence, benign prostatic hyperplasia, and prostate cancer. In addition, the rising incidence of chronic diseases such as diabetes, along with neurological disorders like multiple sclerosis and spinal cord injuries, is driving higher demand for long-term catheterization. As of 1 January 2024, the EU population was estimated at 449.3 million, with more than one-fifth (21.6%) aged 65 years and older, underscoring the growing need for urological care and catheter solutions in the region.

The UK urinary catheters market is evolving, with a focus on patient-centric care, technological innovation, and the adoption of home healthcare. There is an increasing preference for intermittent and external catheters, driven by their safety, comfort, and suitability for self-catheterization at home. Technological advancements, including antimicrobial coatings, hydrophilic materials, and drug-eluting catheters, are helping reduce infection risks and enhance patient outcomes. The market is also induced by the growing aging population and rising prevalence of urological conditions such as urinary incontinence, benign prostatic hyperplasia, and bladder dysfunction.

The rising incidence of prostate cancer in the UK is increasing the demand for urinary catheters, as many patients require catheterization during diagnosis, surgical procedures, and post-operative recovery. Treatments such as radical prostatectomy commonly involve short-term catheter use to allow the bladder and urethra to heal, and urinary retention or leakage is also a frequent complication following surgery or radiotherapy, further extending catheter dependency. In addition, advanced or progressive prostate cancer cases lead to bladder outlet obstruction, requiring intermittent or indwelling catheter use for effective urinary drainage.

• According to Cancer Research UK, Projections indicate that prostate cancer incidence rates in the UK are expected to increase by 15% between 2023-2025 and 2038-2040. By 2038-2040, the number of new prostate cancer cases could reach approximately 85,100 annually.

Asia Pacific Urinary Catheters Market Trends

The Asia Pacific urinary catheters industry is expected to grow at the fastest CAGR from 2026 to 2033. Fueled by a combination of demographic and clinical factors, including a rapidly aging population, the rising prevalence of chronic diseases such as diabetes and neurological disorders, and an increasing burden of urological cancers. Countries like Japan, China, and South Korea are experiencing significant growth in their elderly populations, leading to higher incidences of urinary incontinence and bladder dysfunction. In addition, the rising number of diabetes cases contributes to complications such as neurogenic bladder, further increasing the demand for catheters. The growing prevalence of prostate, bladder, and kidney cancers in the region also necessitates catheterization during post-operative care, collectively accelerating market growth.

The China urinary catheters market is witnessing significant growth, driven by an aging population, rising prevalence of urological disorders, and increasing awareness of advanced urinary management solutions. The growing number of elderly individuals is leading to higher rates of urinary incontinence, benign prostatic hyperplasia, and bladder dysfunction, fueling demand for both intermittent and long-term catheterization. Technological advancements, such as antimicrobial coatings, hydrophilic materials, and patient-friendly designs, are improving safety and comfort, encouraging wider adoption. In addition, the expansion of home healthcare services and government initiatives to improve access to urological care are supporting market growth.

The urinary catheters market in India is expected to grow during the forecast period. The rising incidence of prostate cancer in India is contributing to increased demand for urinary catheters, as affected patients require catheterization during surgical procedures, radiation therapy, and post-operative recovery. Prostate cancer commonly leads to urinary complications such as obstruction, retention, and incontinence, which necessitate the use of intermittent or indwelling catheters for effective bladder management. In addition, a growing number of patients are being diagnosed at advanced stages due to improved awareness and screening, further increasing the need for long-term urinary support in hospital and home-care settings.

"We are observing a rise in prostate cancer cases in young adults, which was earlier associated with adults aged above 50 years. Cancer reports among younger males aged 35 to 44 residing in metropolitan regions have recently increased," - Dr. Ashish Gupta, a medical oncologist certified by the American Board and the chief of the medical oncology department at the Unique Hospital Cancer Center in Delhi.

• According to the International Agency for Research on Cancer projections, which The Lancet has factored in its analysis, prostate cancer incidence in India will double to about 71,000 new cases per year by 2040. Prostate cancer accounts for three per cent of all cancers in India, with an estimated 33,000-42,000 new cases diagnosed annually.

Latin America Urinary Catheters Market Trends

The urinary catheter industry in Latin America is primarily driven by the rising prevalence of chronic diseases such as diabetes, stroke, and spinal cord injuries, all of which contribute to urinary complications requiring catheterization. The region is witnessing a demographic shift with a growing elderly population, particularly in countries such as Brazil and Argentina, where age-related urological conditions such as benign prostatic hyperplasia and incontinence are becoming more common. The increasing number of surgical procedures, especially in urology, gynecology, and orthopedics, further boosts short-term demand for catheters in perioperative care.

Middle East Africa Urinary Catheters Market Trends

The urinary catheter industry in Middle East and Africa (MEA) is witnessing growth, driven by rising disease prevalence, demographic shifts, and expanding healthcare infrastructure. A significant increase in chronic conditions such as diabetes, prostate cancer, urinary incontinence, and spinal cord injuries is fuelling the need for catheter-based urological care. The region's aging population, particularly in GCC countries and South Africa, further drives demand for long-term and intermittent catheterization.

Key Urinary Catheters Company Insights

The urinary catheters market is extremely fragmented, with both major and local market competitors. As current market players step up their efforts to gain a majority share in the market, fierce competition is anticipated, with the level of competition likely to rise further. Many market participants are pursuing various strategic initiatives, such as product launches, mergers and acquisitions, and geographic expansion, to gain a competitive edge over rivals. Thus, with various strategies adopted by market players, the urinary catheters industry is expected to grow over the forecast period.

Key Urinary Catheters Companies

The following key companies have been profiled for this study on the study of the urinary catheters market.

• Coloplast Corp

• B. Braun SE

• Medline Industries, LP.

• Hollister Incorporated

• Cook

• Teleflex Incorporated

• Optimum Medical Limited

• Convatec

• Boston Scientific Corporation

• Ur24Technology, Inc.

• Stryker

• InnoCare Urologics

• Boehringer Laboratories, LLC

• Consure Medical

• TillaCare Ltd.  

• Medtronic

• Urotronic, Inc. (Laborie)

• Silq Technologies

• Cardinal Health

• Wellspect HealthCare, a Dentsply Sirona Company

• GHC German Health Care GmbH

• Sterimed Group

Competitive Benchmarking

Market Dynamics & Strategic Opportunities

The below figure provides a strategic overview of the urinary catheter market, illustrating the industry value chain, key demand drivers, technology advancements, material innovations, and growth opportunities. It is intended to provide a high-level understanding of the market ecosystem, major industry trends, and strategic factors influencing product development, commercialization, and long-term market growth.

Recent Developments

• January 2026, Medline announced the official opening of its new office in Riyadh, Saudi Arabia, marking a strategic expansion of its presence in the Middle East healthcare market. The new facility is designed to strengthen regional operations and improve service delivery across key product segments, including urology products such as urinary care solutions, surgical procedure trays, operating room solutions, wound care, and respiratory products.

• November 2025, AvantGuard, Inc., a biotechnology company developing next-generation antimicrobial technologies inspired by the human immune system, announced that it had received three National Institutes of Health (NIH) research grants totaling USD2.65 million.

• April 2025, Silq Technologies Corporation, a privately owned leader in advanced materials science, secured a national group purchasing agreement and received the Technology Breakthrough Designation from Premier, Inc. Starting April 1, 2025, this agreement enables Premier’s members to access pre-negotiated pricing and terms for ClearTract catheters.

Urinary Catheters Market Report Scope

Global Urinary Catheters Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends across sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global urinary catheters market report based on product, coating type, material, application, gender, end use, distribution channel, and region:

• Product Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Intermittent Catheters

  • Indwelling (Foley) Catheters

    • 2-Way Foley Catheters

    • 3-Way Foley Catheters

    • Specialty Foley Catheters

  • External Catheters

    • Male External Catheters

    • Female External Catheters

  • Suprapubic Catheter

• Coating Type Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Coated Catheters

    • Hydrophilic Coated

    • Antimicrobial Coated

      • Silver Alloy Coated

      • Nitrofurazone Coated

    • Hydrogel Coated

    • PTFE/Silicone Coated

  • Uncoated Catheters

• Material Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Silicone

  • Latex

  • Silicone-Coated Latex

  • PVC

  • Other Materials

• Application Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Urinary Incontinence

  • Benign Prostate Hyperplasia (BPH)

  • Spinal Cord Injury

  • Post-Surgical Urinary Retention

  • Neurogenic Bladder

  • Chronic Urinary Retention

  • Prostate Cancer

  • Other Urological Conditions

• Gender Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Male

  • Female

• End Use Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Hospitals

  • Ambulatory Surgical Centers (ASCs)

  • Clinics

  • Long-term Care Facilities/Nursing Homes

  • Home Care Settings

• Distribution Channel Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • Direct Tenders

  • Distributors/Wholesalers

  • Retail Pharmacies

  • Online Channels

• Regional Outlook (Revenue, USD Million/Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

Research Methodology

The urinary catheters market figures in this report are based on a proven research process that combines executive interviews with secondary research from proprietary databases, company filings, and recognized regulatory and institutional sources. Market size is built through value-chain sizing-reconciling supply-side and demand-side estimates-and triangulated with bottom-up and top-down approaches. Every estimate passes multiple levels of expert validation before publication, with each urinary catheters segment quantified using the revenue-capture definitions in the table below.

Segment Definition

Estimation Model

Delivered Customizations

This report has been delivered with the following In-depth customizations